Cardiatis, SA announces successful treatment of the first popliteal aneurysm patient with the Cardiatis FluidSmart 3D Multilayer Braided Stent. FluidSmart, an investigational device in the European Union, is a next generation technology for endovascular aneurysm repair.

Brussels, Belgium (PRWEB) September 25, 2007 -- Cardiatis, SA announced today the successful treatment of the first popliteal aneurysm patient with the Cardiatis FluidSmart 3D Multilayer Braided Stent. FluidSmart, an investigational device in the European Union, is a next generation technology for endovascular aneurysm repair.

The procedure was performed by Professor Antonios Polydorou at Agios Panteleimon General Hospital of Nikaia in Athens, Greece. The first treated patient, a 75-year old male, on December 14th 2006 underwent a minimally invasive endovascular procedure that placed a Cardiatis FluidSmart hemodynamic modulating stent to treat a 5 cm popliteal aneurysm. Post procedural angiogram showed successful deployment and reduction in flow within aneurysm.

On February 20th 2007, two months following stent implantation, angiography revealed the formation of an organized thrombus within the aneurysm with reduction in aneurysm size.

On July 10th, 2007 the seven-month follow up angiogram revealed complete exclusion of aneurysm from circulation. As of the time of writing, the aneurysm remains excluded from circulation with no recanalization and the patient has resumed full functionality.

"Though rare, popliteal aneurysms can result in severe morbidity. Open surgical repair remains the main method for managing them, however Cardiatis FluidSmart technology offers a novel endovascular approach for difficult to operate cases" stated Professor Polydorou

Popliteal artery aneurysms are the most common peripheral artery aneurysms accounting for up to 85% of the total aneurysms in the periphery. More than 95% of peripheral artery aneurysms occur in males, and the average age of patients at presentation is 65 years. Atherosclerosis appears to be the etiology in more than 90% of cases.

"We are glad that our technology proved to be of help in this humanitarian case" said Noureddine Frid, Cardiatis president and chief executive officer. "We will continue to develop our technology for the endovascular repair of aneurysm in main locations like the aorta and the brain."

About Cardiatis
Cardiatis, an innovative medical technology company located in Belgium, is focused on developing its patented FluidSmart 3D multilayer stent technology platform, a next generation technology for endovascular aneurysm repair. Additional information can be found on Cardiatis web site at www.cardiatis.com.

###

Simillar Articles

Cardiatis Completes Patient Recruitment for Pivotal European Clinical Trial of its FluidSmart 3D...

Cardiatis, SA announced today that it has completed recruitment of patients into its first-in-man European clinical trial of its 3D Multilayer Braided Stent for repairing aneurysms. Patient...

Successful Exclusion of a Renal Artery Aneurysm (RAA) with Cardiatis FluidSmart 3D Multilayer Stent

Cardiatis, SA announces the successful treatment of the first renal artery aneurysm (RAA) patient with the Company's FluidSmart Three Dimensional Multilayer Braided Stent. FluidSmart, an...

Revolutionary New Technique Uses Onyx to Fill Hard-to-Treat Aneurysms

CINN's Dr. Demetrius Lopes is one of the first in the country to use a new noninvasive technique to treat brain aneurysms. The technique involves a new liquid polymer material, Onyx, which is...

Los Angeles Brain and Spine Institute Surgeon Using New Liquid Treatment for Brain Aneurysms

The Los Angeles Brain and Spine Institute today announced that Dr. George Rappard, a neurointerventional surgeon in Glendale, California is the first physician west of the Rockies to treat a...

M2S, Inc. Achieves Milestone with 150,000th Radiographic Scan for Evaluation and Surveillance of...

M2S Inc., an industry leader in endovascular treatment planning and patient registries, announced today that the company has reached a new milestone, having processed over 150,000 radiographic...

Home